Improving the assessment of deep learning models in the context of drug-target interaction prediction
Mirko Torrisi, Antonio de la Vega de León, Guillermo Climent, Remco Loos, Alejandro Panjkovich
This paper improves the assessment of deep learning models for drug-target interaction prediction by addressing dataset biases and proposing a more accurate evaluation framework.
bioRxiv · Apr 20, 2022 · PreprintBioinformatics